Assessment of cardiac sympathetic activity by MIBG imaging in patients with heart failure: a clinical appraisal(317 views) Perrone-Filardi P, Paolillo S, Dellegrottaglie S, Gargiulo P, Savarese G, Marciano C, Casaretti L, Cecere M, Musella F, Pirozzi E, Parente A, Cuocolo A
Department of Internal Medicine, Cardiovascular and Immunological Sciences, Federico II University, Naples, Italy. fpperron@unina.it
Department of Biomorphological and Functional Sciences, Federico II University, Institute of Diagnostic and Nuclear Development, Naples, Italy
References: Carriò, I., Cowie, M.R., Yamazaki, J., Cardiac sympathetic imaging with mIBG in heart failure (2010) JACC Cardiovasc Imaging, 3, pp. 92-10
Dickstein, K., Vardas, P.E., Auricchio, A., 2010 Focused update of ESC guidelines on device therapy in heart failure: An update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association (2010) Eur Heart J, 31, pp. 2677-2687. , Authors/Task Force Members
Haider, N., Balinga, R.R., Chandrashekhar, Y., Adrenergic excess, hNET1 down-regulation, and compromised mIBG uptake in heart failure poverty in the presence of plenty (2010) JACC Cardiovasc Imaging, 3, pp. 71-75
Flotats, A., Carrió, I., Agostini, D., Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology (2010) Eur J Nucl Med Mol Imaging, 37, pp. 1802-1812. , EANM Cardiovascular CommitteeEuropean Council of Nuclear Cardiology
Bax, J.J., Kraft, O., Buxton, A.E., 123I-MIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing: A prospective multicenter pilot study (2008) Circ Cardiovasc Imaging, 1, pp. 131-140
Arora, R., Ferrick, K.J., Nakata, T., Kaplan, R.C., Rozengarten, M., Latif, F., Ng, K., Travin, M.I., I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defribillator (2003) Journal of Nuclear Cardiology, 10 (2), pp. 121-131. , DOI 10.1067/mnc.2003.2
Boogers, M.J., Borleffs, C.J., Henneman, M.M., Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients (2010) J Am Coll Cardiol, 15, pp. 2769-2777
Tamaki, S., Yamada, T., Okuyama, Y., Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: Results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion (2009) J Am Coll Cardiol, 53, pp. 426-435
Katoh, S., Shishido, T., Kutsuzawa, D., Iodine-123-metaiodobenzylguanidine imaging can predict future cardiac events in heart failure patients with preserved ejection fraction (2010) Ann Nucl Med, 24, pp. 679-686
Jacobson, A.F., Senior, R., Cerqueira, M.D., Myocardial Iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study (2010) J Am Coll Cardiol, 55, pp. 2212-2221. , ADMIRE-HF Investigators
Tsukamoto, T., Morita, K., Naya, M., Inubushi, M., Katoh, C., Nishijima, K., Kuge, Y., Tamaki, N., Decreased myocardial beta-adrenergic receptor density in relation to increased sympathetic tone in patients with nonischemic cardiomyopathy (2007) Journal of Nuclear Medicine, 48 (11), pp. 1777-1782. , http://jnm.snmjournals.org/cgi/reprint/48/11/1777, DOI 10.2967/jnumed.107.043794
Agostini, D., Verberne, H.J., Burchert, W., I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: Insights from a retrospective European multicenter study (2008) Eur J Nucl Med Mol Imaging, 35, pp. 535-546
Verberne, H.J., Brewster, L.M., Somsen, G.A., Van Eck-Smit, B.L.F., Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: A systematic review (2008) European Heart Journal, 29 (9), pp. 1147-1159. , DOI 10.1093/eurheartj/ehn113
Kasama, S., Toyama, T., Sumino, H., Prognostic value of cardiac sympathetic nerve activity evaluated by [123I]m-iodobenzylguanidine imaging in patients with ST-segment elevation myocardial infarction (2011) Heart, 97, pp. 20-26
De Marco, T., Dae, M., Yuen-Green, M.S., Iodine-123-metaiodobenzylguanidine scintigraphic assessment of the transplanted human heart: Evidence for late reinnervation (1995) J Am Coll Cardiol, 25, pp. 927-931
Toyama, T., Aihara, Y., Iwasaki, T., Hasegawa, A., Suzuki, T., Nagai, R., Endo, K., Taniguchi, K., Cardiac sympathetic activity estimated by 123I-MIBG myocardial imaging in patients with dilated cardiomyopathy after beta-blocker or angiotensin-converting enzyme inhibitor therapy (1999) Journal of Nuclear Medicine, 40 (2), pp. 217-223
Gerson, M.C., Craft, L.L., McGuire, N., Suresh, D.P., Abraham, W.T., Wagoner, L.E., Carvedilol improves left ventricular function in heart falure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine (2002) Journal of Nuclear Cardiology, 9 (6), pp. 608-615. , DOI 10.1067/mnc.2002.127717
Toyama, T., Hoshizaki, H., Seki, R., Isobe, N., Adachi, H., Naito, S., Oshima, S., Taniguchi, K., Efficacy of amiodarone treatment on cardiac symptom, function, and sympathetic nerve activity in patients with dilated cardiomyopathy: Comparison with beta-blocker therapy (2004) Journal of Nuclear Cardiology, 11 (2), pp. 134-141. , DOI 10.1016/j.nuclcard.2003.11.006, PII S1071358104000121
Drakos, S.G., Athanasoulis, T., Malliaras, K.G., Myocardial sympathetic innervation and long-term left ventricular mechanical unloading (2010) JACC Cardiovasc Imaging, 3, pp. 64-70
Erol-Yilmaz, A., Verberne, H.J., Schrama, T.A., Hrudova, J., De Winter, R.J., Van Eck-Smit, B.L.F., De Bruin, R., Tukkie, R., Cardiac resynchronization induces favorable neurohumoral changes (2005) PACE - Pacing and Clinical Electrophysiology, 28 (4), pp. 304-310. , DOI 10.1111/j.1540-8159.2005.09508.x
Gould, P.A., Kong, G., Kalff, V., Duffy, S.J., Taylor, A.J., Kelly, M.J., Kaye, D.M., Improvement in cardiac adrenergic function post biventricular pacing for heart failure (2007) Europace, 9 (9), pp. 751-756. , DOI 10.1093/europace/eum081
Burri, H., Sunthorn, H., Somsen, A., Fleury, E., Stettler, C., Shah, D., Righetti, A., Improvement in cardiac sympathetic nerve activity in responders to resynchronization therapy (2008) Europace, 10 (3), pp. 374-378. , DOI 10.1093/europace/eun017
Shan, K., Bick, R.J., Poindexter, B.J., Altered adrenergic receptor density in myocardial hibernation in humans: A possible mechanism of depressed myocardial function (2000) Circulation, 102, pp. 2599-2606
Perrone-Filardi, P., Pace, L., Prastaro, M., Squame, F., Betocchi, S., Soricelli, A., Piscione, F., Chiariello, M., Assessment of myocardial viability in patients with chronic coronary artery disease: Rest-4-hour-24-hour 201Tl tomography versus dobutamine echocardiography (1996) Circulation, 94 (11), pp. 2712-2719
Indolfi, C., Piscione, F., Perrone-Filardi, P., Prastaro, M., Di, L.E., Sacca, L., Salvatore, M., Chiariello, M., Inotropic stimulation by dobutamine increases left ventricular regional function at the expense of metabolism in hibernating myocardium (1996) American Heart Journal, 132 (3), pp. 542-549. , DOI 10.1016/S0002-8703(96)90236-7
Pace, L., Perrone-Filardi, P., Mainenti, P., Cuocolo, A., Vezzuto, P., Prastaro, M., Varrone, A., Salvatore, M., Identification of viable myocardium in patients with chronic coronary artery disease using rest-redistribution thallium-201 tomography: Optimal image analysis (1998) Journal of Nuclear Medicine, 39 (11), pp. 1869-1874
Kobayashi, M., Izawa, H., Cheng, X.W., Dobutamine stress testing as a diagnostic tool for evaluation of myocardial contractile reserve in asymptomatic or mildly symptomatic patients with dilated cardiomyopathy (2008) JACC Cardiovasc Imaging, 1, pp. 718-726
Assessment of cardiac sympathetic activity by MIBG imaging in patients with heart failure: a clinical appraisal
Cardiac sympathetic activity can be assessed by (123)I-labelled meta-iodobenzylguanidine (MIBG) scintigraphy. Abnormalities of sympathetic cardiac activity have been shown in patients with heart failure, resulting in reduced MIBG uptake. Abnormal MIBG uptake predicts cardiac death, arrhythmias and all-cause mortality in patients with heart failure with a prognostic power incremental to that of conventional risk markers, and may identify patients at low risk of arrhythmias despite current guideline indications for implantable cardioverter defibrillator or patients at high risk for arrhythmias not fulfilling implantable cardioverter defibrillator indications. Prospective outcome studies are needed to assess whether MIBG imaging will have an impact on the mortality and morbidity of patients with heart failure.
Assessment of cardiac sympathetic activity by MIBG imaging in patients with heart failure: a clinical appraisal
No results.
Assessment of cardiac sympathetic activity by MIBG imaging in patients with heart failure: a clinical appraisal
Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, Bengel F, Busemann Sokole E, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie PY, Mckiddie F, O'connor M, Prvuolovich E, Underwood R * 3. 0 T perfusion MR imaging(692 views) Rivista Di Neuroradiologia (ISSN: 1120-9976), 2004; 17(6): 807-812. Impact Factor:0.023 ViewExport to BibTeXExport to EndNote